Skip to main content

Web Exclusives

In the News, Lung Cancer, Oncology
New Data Show Osimertinib Effective as First-Line Treatment of NSCLC with EGFR Mutation
Lilly Ostrovsky
Read More
FDA Approvals
Atezolizumab First PD-L1 Inhibitor Approved by the FDA for Advanced or Metastatic Urothelial Cancer
Read More
FDA Approvals, In the News
Venclexta FDA Approved for Patients with CLL
Read More
Letters to the Editor, In the News
Correspondence: Developing a Model Framework to Assess Cost of Therapy
Read More
FDA Approvals, In the News
FDA Approves Infliximab Biosimilar for Multiple Indications
Read More
FDA Approvals, In the News
FDA Expands Use of Xalkori to Treat Rare Form of Advanced Non-Small Cell Lung Cancer
Read More
FDA Approvals, In the News
FDA Approves First Treatment for Rare Disease in Patients Who Receive Stem Cell Transplant from Blood or Bone Marrow
Read More
FDA Approvals, In the News
FDA Approves First Coagulation Factor-Albumin Fusion Protein to Treat Patients with Hemophilia B
Read More
FDA Approvals, In the News
FDA Approves Integra Omnigraft Dermal Regeneration Matrix to Treat Diabetic Foot Ulcers
Read More
FDA Approvals
Onivyde (Irinotecan Liposome Injection) a New Treatment Option for Patients with Metastatic Pancreatic Cancer
Read More
Page 24 of 37
Results 231 - 240 of 366